Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MON2 regulator of endosome-to-Golgi trafficking (MON2) is a conserved scaffold protein essential for proper vesicular transport between endosomes and the Golgi apparatus. MON2 localizes primarily to the trans-Golgi network and recycling endosomes[1][2]. Depletion of MON2 in mammalian cells accelerates the retrograde trafficking of transmembrane proteins such as furin and cation-independent mannose 6-phosphate receptor, suggesting it suppresses endosome-to-Golgi delivery under normal conditions[1]. In yeast, MON2 regulates retrograde transport, endocytosis, and vacuole biogenesis, interacting with proteins such as Dop1, Neo1, and GGA1. MON2 is required for the upregulation of autophagy, particularly under cellular stress (e.g., starvation), enhancing autophagosome formation via interaction with GABARAPL2[2][3]. Its role is implicated in the regulation of longevity in organisms, including *C. elegans*, by mediating trafficking and proper localization of autophagy factors, but no drugs, clinical biomarkers, or direct disease roles are currently established for MON2 in human medicine[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MON2 regulator of endosome-to-Golgi trafficking (MON2).